First detection of 'odor profile' for skin cancer may lead to rapid, non-invasive diagnostic test

August 20, 2008,

Chemists today described the first identification of a specific "odor profile" for skin cancer, a discovery that could form the basis of a rapid, non-invasive test for diagnosing the most common type of cancer in the United States. The findings may enable doctors in the future to diagnose skin cancer quickly and accurately by waving a handheld scanner or sensor above the skin, they reported today at the 236th national meeting of the American Chemical Society.

Skin cancer is on the rise in this country, particularly among women under age 40. The new findings could lead to the development of diagnostic tools that could potentially save lives by detecting skin cancer before there are any outward signs, such as suspicious moles, the researchers say.

Diagnosing diseases on the basis of their characteristic odors is not new. For centuries, doctors relied on their sense of smell to identify signs of human illnesses. Sweet-smelling breath was a tell-tale sign of diabetes, while a foul-odor emitted by a wound indicated infection.

In the new study, Michelle Gallagher, Ph.D., and colleagues point out that scientists recently demonstrated that dogs can be trained to detect skin tumors because the tumors have a different smell than normal skin. Taking cues from this study, the researchers found that the skin of people with skin cancer releases a chemical odor profile very different from that of people without skin cancer.

"Researchers have speculated that tumors give off different odors, but we're the first to identify and quantify the compounds involved in skin cancer odors," says Gallagher, an analytical chemist who conducted the study while working as a post-doctoral researcher under George Preti, Ph.D., also a chemist, at the Monell Chemical Senses Center in Philadelphia.

"This research opens doors to potential new approaches to skin cancer diagnosis based on the profile of skin odors, hopefully leading to more rapid and non-invasive detection and diagnosis of this prevalent disease," says Gallagher, now a chemist with Rohm and Haas in Spring House, Penn.

To examine whether skin odors change in people with skin cancer, Gallagher and colleagues used advanced chromatography techniques to sample and analyze the air above tumor sites in 11 patients diagnosed with basal cell carcinoma, the most common type of skin cancer with more than one million new cases every year. They compared the profile of chemicals detected above the tumor sites to profiles obtained from skin of 11 individuals without cancer.

"We found a different profile of chemicals above tumor sites relative to healthy skin," says Gallagher. "The same chemicals are present, but at skin cancer sites some chemicals are increased, while others are decreased compared to healthy individuals." She declined to give specific details about the chemicals found, noting that the researchers had applied for a patent on their technique.

The scientists eventually plan to identify a reliable "odor profile" of all three forms of skin cancer, including squamous cell cancer and melanoma, the deadliest form. If successful, the researchers hope to combine their method with emerging nano-sensor "electronic nose" technology designed to identify odorous chemicals. Gallagher envisions a wand-like "E-nose" that can be moved across the skin and will set off an alarm or beep when cancer is detected, similar to the fictional medical "tricorder" from Star Trek.

Skin cancer is currently diagnosed by conducting a biopsy of suspicious moles or lesions on the skin, which can be a slow and painful process. In cases where there are no physical signs of skin cancer, the disease can be extremely difficult to detect, leading to a delayed or missed diagnosis. Having a diagnostic method to detect skin cancer without any apparent signs would give doctors a head-start in fighting the disease, the researchers say. Funding for this study was provided, in-part, by the National Institutes of Health.

Source: American Chemical Society

Explore further: African-American, Caucasian women should take identical vitamin D doses

Related Stories

African-American, Caucasian women should take identical vitamin D doses

February 12, 2013
African-American women battling vitamin D deficiencies need the same dose as Caucasian women to treat the condition, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology ...

Research collaboration identifies biomarker panel linked to melanoma patient survival

June 6, 2017
An international research collaboration led by University College Dublin (UCD), involving the UCD spin-out company OncoMark and Bellvitge Biomedical Research Institute in Barcelona, has identified a set of biomarkers strongly ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.